490 related articles for article (PubMed ID: 21270273)
1. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.
Kitada M; Kume S; Imaizumi N; Koya D
Diabetes; 2011 Feb; 60(2):634-43. PubMed ID: 21270273
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.
Kim MY; Lim JH; Youn HH; Hong YA; Yang KS; Park HS; Chung S; Ko SH; Shin SJ; Choi BS; Kim HW; Kim YS; Lee JH; Chang YS; Park CW
Diabetologia; 2013 Jan; 56(1):204-17. PubMed ID: 23090186
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
Park HS; Lim JH; Kim MY; Kim Y; Hong YA; Choi SR; Chung S; Kim HW; Choi BS; Kim YS; Chang YS; Park CW
J Transl Med; 2016 Jun; 14(1):176. PubMed ID: 27286657
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway.
Wang X; Meng L; Zhao L; Wang Z; Liu H; Liu G; Guan G
Diabetes Res Clin Pract; 2017 Apr; 126():172-181. PubMed ID: 28258028
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.
Chang CC; Chang CY; Wu YT; Huang JP; Yen TH; Hung LM
J Biomed Sci; 2011 Jun; 18(1):47. PubMed ID: 21699681
[TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats.
Hussein MM; Mahfouz MK
Biomed Pharmacother; 2016 Aug; 82():685-92. PubMed ID: 27470412
[TBL] [Abstract][Full Text] [Related]
9. Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice.
Lee YE; Kim JW; Lee EM; Ahn YB; Song KH; Yoon KH; Kim HW; Park CW; Li G; Liu Z; Ko SH
PLoS One; 2012; 7(11):e50412. PubMed ID: 23226280
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Wang F; Li R; Zhao L; Ma S; Qin G
Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice.
Hong YA; Lim JH; Kim MY; Kim TW; Kim Y; Yang KS; Park HS; Choi SR; Chung S; Kim HW; Kim HW; Choi BS; Chang YS; Park CW
PLoS One; 2014; 9(5):e96147. PubMed ID: 24801481
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway.
Guo H; Chen Y; Liao L; Wu W
Cardiovasc Drugs Ther; 2013 Jun; 27(3):189-98. PubMed ID: 23358928
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway.
Maki T; Maeda Y; Sonoda N; Makimura H; Kimura S; Maeno S; Takayanagi R; Inoguchi T
Metabolism; 2017 Jun; 71():33-45. PubMed ID: 28521876
[TBL] [Abstract][Full Text] [Related]
15. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
[TBL] [Abstract][Full Text] [Related]
16. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
17. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat.
Ma L; Fu R; Duan Z; Lu J; Gao J; Tian L; Lv Z; Chen Z; Han J; Jia L; Wang L
Pathol Res Pract; 2016 Apr; 212(4):310-8. PubMed ID: 26872534
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose.
Hou S; Zheng F; Li Y; Gao L; Zhang J
Int J Mol Sci; 2014 Aug; 15(9):15026-43. PubMed ID: 25162824
[TBL] [Abstract][Full Text] [Related]
19. Reduction of diabetes-induced renal oxidative stress by a cantaloupe melon extract/gliadin biopolymers, oxykine, in mice.
Naito Y; Akagiri S; Uchiyama K; Kokura S; Yoshida N; Hasegawa G; Nakamura N; Ichikawa H; Toyokuni S; Ijichi T; Yoshikawa T
Biofactors; 2005; 23(2):85-95. PubMed ID: 16179750
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of brown adipose tissue activation in diabetic mice.
Cai YY; Zhang HB; Fan CX; Zeng YM; Zou SZ; Wu CY; Wang L; Fang S; Li P; Xue YM; Guan MP
J Diabetes; 2019 Dec; 11(12):958-970. PubMed ID: 31020790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
